Recursion Pharmaceuticals annual gross profit
2020
2021
2022
2023
2024
2025
Recursion Pharmaceuticals Gross Profit Growth & History (RXRX)
Recursion Pharmaceuticals's gross profit was $3.7M for fiscal 2025.
View full Recursion Pharmaceuticals company overviewRecursion Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.7M | −$9.9M | −72.59% |
| 2024 | 2024-12-31 | $13.6M | $11.6M | +584.15% |
| 2023 | 2023-12-31 | $2.0M | $10.4M | — |
| 2022 | 2022-12-31 | −$8.4M | −$18.6M | — |
| 2021 | 2021-12-31 | $10.2M | $6.2M | +156.89% |
| 2020 | 2020-12-31 | $4.0M | — | — |
Recursion Pharmaceuticals quarterly gross profit
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$3.8M | −$2.9M | — |
| Q1 2026 | 2026-03-31 | −$6.0M | $1.1M | — |
| Q4 2025 | 2025-12-31 | $21.3M | $29.5M | — |
| Q3 2025 | 2025-09-30 | −$9.5M | −$23.5M | — |
| Q2 2025 | 2025-06-30 | −$938,000 | −$6.2M | — |
| Q1 2025 | 2025-03-31 | −$7.1M | −$9.7M | — |
| Q4 2024 | 2024-12-31 | −$8.2M | −$9.3M | — |
| Q3 2024 | 2024-09-30 | $14.0M | $14.3M | — |
| Q2 2024 | 2024-06-30 | $5.2M | $3.6M | +219.14% |
| Q1 2024 | 2024-03-31 | $2.6M | $2.9M | — |
| Q4 2023 | 2023-12-31 | $1.0M | −$1.8M | −64.35% |
| Q3 2023 | 2023-09-30 | −$344,000 | $1.9M | — |
| Q2 2023 | 2023-06-30 | $1.6M | $8.2M | — |
| Q1 2023 | 2023-03-31 | −$314,000 | $2.2M | — |
| Q4 2022 | 2022-12-31 | $2.8M | $303,000 | +11.96% |
| Q3 2022 | 2022-09-30 | −$2.2M | −$4.8M | — |
| Q2 2022 | 2022-06-30 | −$6.6M | −$9.1M | — |
| Q1 2022 | 2022-03-31 | −$2.5M | −$5.0M | — |
| Q4 2021 | 2021-12-31 | $2.5M | — | — |
| Q3 2021 | 2021-09-30 | $2.5M | — | — |
| Q2 2021 | 2021-06-30 | $2.5M | — | — |
| Q1 2021 | 2021-03-31 | $2.6M | — | — |
Recursion Pharmaceuticals gross profit trends
Over the last five fiscal years, Recursion Pharmaceuticals's gross profit decreased from $4.0M to $3.7M, a change of −$234,000. The latest reported quarter, Q2 2026, shows −$3.8M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Recursion Pharmaceuticals source filings ↗